Vicapsys Life Sciences Total Assets Growth & History (VICP)
Vicapsys Life Sciences's total assets was $39,656 for fiscal 2023.
View full Vicapsys Life Sciences company overviewVicapsys Life Sciences annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2023 | 2023-12-31 | $39,656 | −$32,365 | −44.94% |
| 2022 | 2022-12-31 | $72,021 | −$522,292 | −87.88% |
| 2021 | 2021-12-31 | $594,313 | $190,195 | +47.06% |
| 2020 | 2020-12-31 | $404,118 | −$294,321 | −42.14% |
| 2019 | 2019-12-31 | $698,439 | — | — |
Vicapsys Life Sciences quarterly total assets
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q3 2024 | 2024-09-30 | $89,569 | −$118,917 | −57.04% |
| Q4 2023 | 2023-12-31 | $39,656 | −$32,365 | −44.94% |
| Q3 2023 | 2023-09-30 | $208,486 | −$175,315 | −45.68% |
| Q2 2023 | 2023-06-30 | $378,147 | −$4,058 | −1.06% |
| Q1 2023 | 2023-03-31 | $63,293 | −$414,902 | −86.76% |
| Q4 2022 | 2022-12-31 | $72,021 | −$522,292 | −87.88% |
| Q3 2022 | 2022-09-30 | $383,801 | −$168,371 | −30.49% |
| Q2 2022 | 2022-06-30 | $382,205 | −$180,204 | −32.04% |
| Q1 2022 | 2022-03-31 | $478,195 | $49,790 | +11.62% |
| Q4 2021 | 2021-12-31 | $594,313 | $190,195 | +47.06% |
| Q3 2021 | 2021-09-30 | $552,172 | $137,890 | +33.28% |
| Q2 2021 | 2021-06-30 | $562,409 | $134,992 | +31.58% |
| Q1 2021 | 2021-03-31 | $428,405 | −$32,638 | −7.08% |
| Q4 2020 | 2020-12-31 | $404,118 | −$294,321 | −42.14% |
| Q3 2020 | 2020-09-30 | $414,282 | — | — |
| Q2 2020 | 2020-06-30 | $427,417 | — | — |
| Q1 2020 | 2020-03-31 | $461,043 | — | — |
| Q4 2019 | 2019-12-31 | $698,439 | — | — |
Vicapsys Life Sciences total assets trends
Between the periods ended 2019-12-31 and 2023-12-31, Vicapsys Life Sciences's total assets decreased from $698,439 to $39,656, a change of −$658,783. The latest reported quarter, Q3 2024, shows $89,569.
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Vicapsys Life Sciences source filings ↗